TNF-alpha inhibitor monoclonal antibody

This page covers all TNF-alpha inhibitor monoclonal antibody drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting TNF-alpha (Tumor Necrosis Factor-alpha).

Targets

TNF-alpha (Tumor Necrosis Factor-alpha)

Marketed (1)

• PRECISION dosing Infliximab · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Immunology
  Infliximab is a TNF-alpha inhibitor monoclonal antibody that binds and neutralizes tumor necrosis factor-alpha to reduce inflammatory responses.